Pharmaceutical sector Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth 5 hours ago Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a… Glenmark Rallies as Q3 Margins Expand, FDA Clears U.S. Facility 6 hours ago Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) The Mumbai-based pharmaceutical company posts strong domestic and international sales as it transitions toward an…